Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis

Prevalence of cardiovascular risk factors in patients with psoriasis

Andrea L. Neimann, Daniel B. Shin, Xingmei Wang et al. · Journal of the American Academy of Dermatology · 2006 · 1K citations

Medicine, Clinical Sciences, Dermatology +9

Psoriasis of early and late onset: Characterization of two types of psoriasis vulgaris

Tilo Henseler, Enno Christophers · Journal of the American Academy of Dermatology · 1985 · 1K citations

Medicine, Dermatology, Pathology +11

Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial

Alan Menter, Stephen K. Tyring, Kenneth B. Gordon et al. · Journal of the American Academy of Dermatology · 2007 · 883 citations

Life Sciences, Dermatology, Immunology +10

Psoriasis Is Common, Carries a Substantial Burden Even When Not Extensive, and Is Associated with Widespread Treatment Dissatisfaction

Robert S. Stern, Tamar Nijsten, Steven R. Feldman et al. · Journal of Investigative Dermatology Symposium Proceedings · 2004 · 739 citations · Full text

Medicine, Dermatology, Rheumatology +8

Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis

Dorothea M. Sommer, Stefan Jenisch, M Suchán et al. · Archives of Dermatological Research · 2006 · 670 citations

Medicine, Clinical Sciences, Dermatology +9